 | • レポートコード：20QY06-03021 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ピモジドのグローバル市場について種類別（1Mg、2Mg、4Mg）、用途別（病院、ドラッグストア、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ピモジド市場の概要 ・世界の主要地域別ピモジド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のピモジド市場規模2015-2026：種類別（1Mg、2Mg、4Mg） ・世界のピモジド市場規模2015-2026：用途別（病院、ドラッグストア、その他） ・ピモジドの北米市場規模2015-2020 ・ピモジドのヨーロッパ市場規模2015-2020 ・ピモジドの中国市場規模2015-2020 ・ピモジドの日本市場規模2015-2020 ・ピモジドの東南アジア市場規模2015-2020 ・ピモジドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Par Pharmaceutical、Johnson & Johnson、Eumedica、Pharmascience、Domina Pharmaceuticals、Aa Pharma） ・ピモジドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ピモジドの市場動向・機会・課題 ・調査の結論 |
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
Market Analysis and Insights: Global Pimozide Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pimozide market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pimozide industry.
Based on our recent survey, we have several different scenarios about the Pimozide YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 12 million in 2019. The market size of Pimozide will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Pimozide Scope and Market Size
The global Pimozide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pimozide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pimozide market is segmented into
1Mg
2Mg
4Mg
Segment by Application, the Pimozide market is segmented into
Hospitals
Drugstores
Others
The Pimozide market is analysed and market size information is provided by regions (countries). Segment by Application, the Pimozide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pimozide Market Share Analysis
Pimozide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pimozide business, the date to enter into the Pimozide market, Pimozide product introduction, recent developments, etc.
The major vendors covered:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
…
1 Pimozide Market Overview
1.1 Pimozide Product Scope
1.2 Pimozide Segment by Type
1.2.1 Global Pimozide Sales by Type (2020-2026)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Pimozide Segment by Application
1.3.1 Global Pimozide Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Pimozide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pimozide Sales Growth Rate (2015-2026)
1.4.2 Global Pimozide Revenue and Growth Rate (2015-2026)
1.4.3 Global Pimozide Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pimozide Industry Impact
1.5.1 How the Covid-19 is Affecting the Pimozide Industry
1.5.1.1 Pimozide Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pimozide Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pimozide Players to Combat Covid-19 Impact
2 Pimozide Estimate and Forecast by Region
2.1 Global Pimozide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pimozide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pimozide Sales Market Share by Region (2015-2020)
2.2.2 Global Pimozide Revenue Market Share by Region (2015-2020)
2.3 Global Pimozide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pimozide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pimozide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pimozide Estimates and Projections (2015-2026)
2.4.2 Europe Pimozide Estimates and Projections (2015-2026)
2.4.3 China Pimozide Estimates and Projections (2015-2026)
2.4.4 Japan Pimozide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pimozide Estimates and Projections (2015-2026)
2.4.6 India Pimozide Estimates and Projections (2015-2026)
3 Global Pimozide Competition Landscape by Players
3.1 Global Top Pimozide Players by Sales (2015-2020)
3.2 Global Top Pimozide Players by Revenue (2015-2020)
3.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pimozide as of 2019)
3.4 Global Pimozide Average Price by Company (2015-2020)
3.5 Manufacturers Pimozide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pimozide Players (Opinion Leaders)
4 Global Pimozide Market Size by Type
4.1 Global Pimozide Historic Market Review by Type (2015-2020)
4.1.1 Global Pimozide Sales Market Share by Type (2015-2020)
4.1.2 Global Pimozide Revenue Market Share by Type (2015-2020)
4.1.3 Global Pimozide Price by Type (2014-2020)
4.2 Global Pimozide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pimozide Sales Forecast by Type (2021-2026)
4.2.2 Global Pimozide Revenue Forecast by Type (2021-2026)
4.2.3 Global Pimozide Price Forecast by Type (2021-2026)
5 Global Pimozide Market Size by Application
5.1 Global Pimozide Historic Market Review by Application (2015-2020)
5.1.1 Global Pimozide Sales Market Share by Application (2015-2020)
5.1.2 Global Pimozide Revenue Market Share by Application (2015-2020)
5.1.3 Global Pimozide Price by Application (2015-2020)
5.2 Global Pimozide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pimozide Sales Forecast by Application (2021-2026)
5.2.2 Global Pimozide Revenue Forecast by Application (2021-2026)
5.2.3 Global Pimozide Price Forecast by Application (2021-2026)
3 North America Pimozide Market Facts & Figures
3.2 North America Pimozide Sales Market Share by Company (2015-2020)
3.3 North America Pimozide Sales Market Share by Type (2015-2020)
3.4 North America Pimozide Sales Market Share by Application (2015-2020)
4 Europe Pimozide Market Facts & Figures
4.2 Europe Pimozide Sales Market Share by Company (2015-2020)
4.3 Europe Pimozide Sales Market Share by Type (2015-2020)
4.4 Europe Pimozide Sales Market Share by Application (2015-2020)
5 China Pimozide Market Facts & Figures
5.2 China Pimozide Sales Market Share by Company (2015-2020)
5.3 China Pimozide Sales Market Share by Type (2015-2020)
5.4 China Pimozide Sales Market Share by Application (2015-2020)
6 Japan Pimozide Market Facts & Figures
6.2 Japan Pimozide Sales Market Share by Company (2015-2020)
6.3 Japan Pimozide Sales Market Share by Type (2015-2020)
6.4 Japan Pimozide Sales Market Share by Application (2015-2020)
7 Southeast Asia Pimozide Market Facts & Figures
7.2 Southeast Asia Pimozide Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pimozide Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pimozide Sales Market Share by Application (2015-2020)
8 India Pimozide Market Facts & Figures
8.2 India Pimozide Sales Market Share by Company (2015-2020)
8.3 India Pimozide Sales Market Share by Type (2015-2020)
8.4 India Pimozide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pimozide Business
12.1 Teva
12.1.1 Teva Pimozide Corporation Information
12.1.2 Teva Pimozide Business Overview and Total Revenue
12.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Pimozide Products Offered
12.1.5 Teva Recent Development
12.2 Par Pharmaceutical
12.2.1 Par Pharmaceutical Pimozide Corporation Information
12.2.2 Par Pharmaceutical Pimozide Business Overview and Total Revenue
12.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Par Pharmaceutical Pimozide Products Offered
12.2.5 Par Pharmaceutical Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Pimozide Corporation Information
12.3.2 Johnson & Johnson Pimozide Business Overview and Total Revenue
12.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Pimozide Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Eumedica
12.4.1 Eumedica Pimozide Corporation Information
12.4.2 Eumedica Pimozide Business Overview and Total Revenue
12.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eumedica Pimozide Products Offered
12.4.5 Eumedica Recent Development
12.5 Pharmascience
12.5.1 Pharmascience Pimozide Corporation Information
12.5.2 Pharmascience Pimozide Business Overview and Total Revenue
12.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pharmascience Pimozide Products Offered
12.5.5 Pharmascience Recent Development
12.6 Domina Pharmaceuticals
12.6.1 Domina Pharmaceuticals Pimozide Corporation Information
12.6.2 Domina Pharmaceuticals Pimozide Business Overview and Total Revenue
12.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Domina Pharmaceuticals Pimozide Products Offered
12.6.5 Domina Pharmaceuticals Recent Development
12.7 Aa Pharma
12.7.1 Aa Pharma Pimozide Corporation Information
12.7.2 Aa Pharma Pimozide Business Overview and Total Revenue
12.7.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aa Pharma Pimozide Products Offered
12.7.5 Aa Pharma Recent Development
…
13 Pimozide Manufacturing Cost Analysis
13.1 Pimozide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pimozide
13.4 Pimozide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pimozide Distributors List
14.3 Pimozide Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pimozide Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Pimozide Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pimozide Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pimozide Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pimozide Players to Combat Covid-19 Impact
Table 8. Global Market Pimozide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pimozide Sales (K Units) by Region (2015-2020)
Table 10. Global Pimozide Sales Market Share by Region (2015-2020)
Table 11. Global Pimozide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pimozide Revenue Share by Region (2015-2020)
Table 13. Global Pimozide Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Pimozide Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pimozide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pimozide Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pimozide (K Units) of Key Companies (2015-2020)
Table 18. Global Pimozide Sales Share by Company (2015-2020)
Table 19. Global Pimozide Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pimozide Revenue Share by Company (2015-2020)
Table 21. Global Pimozide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pimozide as of 2019)
Table 22. Global Pimozide Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Pimozide Manufacturing Sites and Area Served
Table 24. Manufacturers Pimozide Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pimozide Players
Table 27. Global Pimozide Sales (K Units) by Type (2015-2020)
Table 28. Global Pimozide Sales Share by Type (2015-2020)
Table 29. Global Pimozide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pimozide Price (K Units) by Type (2015-2020)
Table 31. Global Pimozide Sales Share by Type (2021-2026)
Table 32. Global Pimozide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pimozide Revenue Share by Type (2021-2026)
Table 34. Global Pimozide Price (K Units) by Type (2021-2026)
Table 35. Global Pimozide Sales (K Units) by Application (2015-2020)
Table 36. Global Pimozide Sales Share by Application (2015-2020)
Table 37. Global Pimozide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pimozide Price (K Units) by Application (2015-2020)
Table 39. Global Pimozide Sales (K Units) by Application (2021-2026)
Table 40. Global Pimozide Sales Share by Application (2021-2026)
Table 41. Global Pimozide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pimozide Revenue Share by Application (2021-2026)
Table 43. Global Pimozide Price (K Units) by Application (2021-2026)
Table 44. United States Pimozide Sales (K Units) by Company (2015-2020)
Table 45. United States Pimozide Sales Market Share by Company (2015-2020)
Table 46. United States Pimozide Sales (K Units) by Type (2015-2020)
Table 47. United States Pimozide Sales Market Share by Type (2015-2020)
Table 48. United States Pimozide Sales (K Units) by Application (2015-2020)
Table 49. United States Pimozide Sales Market Share by Application (2015-2020)
Table 50. Europe Pimozide Sales (K Units) by Company (2015-2020)
Table 51. Europe Pimozide Sales Market Share by Company (2015-2020)
Table 52. Europe Pimozide Sales (K Units) by Type (2015-2020)
Table 53. Europe Pimozide Sales Market Share by Type (2015-2020)
Table 54. Europe Pimozide Sales (K Units) by Application (2015-2020)
Table 55. Europe Pimozide Sales Market Share by Type (2015-2020)
Table 56. China Pimozide Sales (K Units) by Company (2015-2020)
Table 57. China Pimozide Sales Market Share by Company (2015-2020)
Table 58. China Pimozide Sales (K Units) by Type (2015-2020)
Table 59. China Pimozide Sales Market Share by Type (2015-2020)
Table 60. China Pimozide Sales (K Units) by Application (2015-2020)
Table 61. China Pimozide Sales Market Share by Application (2015-2020)
Table 62. Japan Pimozide Sales (K Units) by Company (2015-2020)
Table 63. Japan Pimozide Sales Market Share by Company (2015-2020)
Table 64. Japan Pimozide Sales (K Units) by Type (2015-2020)
Table 65. Japan Pimozide Sales Market Share by Type (2015-2020)
Table 66. Japan Pimozide Sales (K Units) by Application (2015-2020)
Table 67. Japan Pimozide Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pimozide Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Pimozide Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pimozide Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Pimozide Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pimozide Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Pimozide Sales Market Share by Application (2015-2020)
Table 74. India Pimozide Sales (K Units) by Company (2015-2020)
Table 75. India Pimozide Sales Market Share by Company (2015-2020)
Table 76. India Pimozide Sales (K Units) by Type (2015-2020)
Table 77. India Pimozide Sales Market Share by Type (2015-2020)
Table 78. India Pimozide Sales (K Units) by Application (2015-2020)
Table 79. India Pimozide Sales Market Share by Application (2015-2020)
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva Pimozide Product
Table 84. Teva Recent Development
Table 85. Par Pharmaceutical Corporation Information
Table 86. Par Pharmaceutical Description and Business Overview
Table 87. Par Pharmaceutical Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Par Pharmaceutical Pimozide Product
Table 89. Par Pharmaceutical Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Pimozide Product
Table 94. Johnson & Johnson Recent Development
Table 95. Eumedica Corporation Information
Table 96. Eumedica Description and Business Overview
Table 97. Eumedica Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Eumedica Pimozide Product
Table 99. Eumedica Recent Development
Table 100. Pharmascience Corporation Information
Table 101. Pharmascience Description and Business Overview
Table 102. Pharmascience Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pharmascience Pimozide Product
Table 104. Pharmascience Recent Development
Table 105. Domina Pharmaceuticals Corporation Information
Table 106. Domina Pharmaceuticals Description and Business Overview
Table 107. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Domina Pharmaceuticals Pimozide Product
Table 109. Domina Pharmaceuticals Recent Development
Table . Aa Pharma Corporation Information
Table . Aa Pharma Description and Business Overview
Table . Aa Pharma Pimozide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Aa Pharma Pimozide Product
Table . Aa Pharma Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Pimozide Distributors List
Table 118. Pimozide Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Pimozide Product Picture
Figure 2. Global Pimozide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pimozide Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Drugstores Examples
Figure 8. Others Examples
Figure 9. Global Pimozide Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Pimozide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pimozide Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Pimozide Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pimozide Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pimozide Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pimozide Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pimozide Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pimozide Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pimozide Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pimozide Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pimozide Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pimozide Players Market Share by Revenue in Pimozide 2015 & 2019
Figure 27. Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pimozide Revenue Share by Type (2015-2020)
Figure 29. Global Pimozide Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pimozide Revenue Share by Application (2015-2020)
Figure 31. Global Pimozide Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pimozide Sales Market Share by Type in 2019
Figure 33. United States Pimozide Sales Market Share by Type in 2019
Figure 34. Europe Pimozide Sales Market Share by Company in 2019
Figure 35. Europe Pimozide Sales Market Share by Type in 2019
Figure 36. Europe Pimozide Sales Market Share by Application in 2019
Figure 37. China Pimozide Sales Market Share by Company in 2019
Figure 38. China Pimozide Sales Market Share by Type in 2019
Figure 39. China Pimozide Sales Market Share by Application in 2019
Figure 40. Japan Pimozide Sales Market Share by Company in 2019
Figure 41. Japan Pimozide Sales Market Share by Type in 2019
Figure 42. Japan Pimozide Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pimozide Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pimozide Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pimozide Sales Market Share by Application in 2019
Figure 46. India Pimozide Sales Market Share by Company in 2019
Figure 47. India Pimozide Sales Market Share by Type in 2019
Figure 48. India Pimozide Sales Market Share by Application in 2019
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eumedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pharmascience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Domina Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Aa Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Pimozide
Figure 58. Manufacturing Process Analysis of Pimozide
Figure 59. Pimozide Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
歯科薬の世界市場レポート2020 A recently published report by QY Research titled Global Dental Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…- 口内潰瘍治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Mouth Ulcer Treatment Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …
- LEDブランケットの世界市場レポート2020 The LED blanket is used to treat newborns with jaundice and delivers light through a fiber optic cable to a pad. The pad is placed on the baby's back. Market Analysis and Insights: Global LED Blanket Market The global LED Blanket market was valued at US$ xx million in 2019 and will reach US$ xx mill…
- アミノフィリンの世界市場レポート2020 Market Analysis and Insights: Global Aminophylline Market The global Aminophylline market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Aminophylline Scope and Market Size The global Aminophylline market is se…
- 大動脈内カウンターパルセーション装置の世界市場レポート2020 Market Analysis and Insights: Global Intra Aortic Counterpulsation Device Market The global Intra Aortic Counterpulsation Device market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Intra Aortic Counterpulsati…